Metabolism

Items 41-50 of 116

per page
Set Descending Direction
  1. Lac-Phe . acetate
    CAS  183241-73-8
    AG-CR1-3545
    AG-CR1-3545-M01010 mg
    CHF 140.00
    AG-CR1-3545-M05050 mg
    CHF 560.00
    Lac-Phe . acetate
  2. Lipofermata
    CAS  297180-15-5
    AG-CR1-3542
    AG-CR1-3542-M01010 mg
    CHF 110.00
    AG-CR1-3542-M05050 mg
    CHF 440.00
    Lipofermata
  3. Liraglutide
    CAS  204656-20-2
    AG-CP3-0034
    AG-CP3-0034-M0011 mg
    CHF 95.00
    AG-CP3-0034-M0055 mg
    CHF 210.00
    AG-CP3-0034-M02525 mg
    CHF 590.00

    BULK available!
    Research Use Only (RUO). NOT ALLOWED FOR USE IN HUMANS.

    Learn more about GLP-1 & GIP Receptor Agonists

    Liraglutide
  4. Metformin . hydrochloride
    CAS  1115-70-4
    AG-CR1-3689
    AG-CR1-3689-G0011 g
    CHF 27.00
    AG-CR1-3689-G0055 g
    CHF 40.00
    Metformin . hydrochloride
  5. Metformin Lipodisq™ Sterile Solution
    CAS  1115-70-4
    IAX-700-103
    IAX-700-103-L0011 ml
    CHF 244.00
    Metformin Lipodisq™ Sterile Solution
  6. MOTS-c (human)
    CAS  1627580-64-6
    AG-CP3-0026
    AG-CP3-0026-M0011 mg
    CHF 180.00
    AG-CP3-0026-M0055 mg
    CHF 630.00
    MOTS-c (human)
  7. MOTS-c (K14Q Mutant) (human)
    AG-CP3-0033
    AG-CP3-0033-M0011 mg
    CHF 180.00
    AG-CP3-0033-M0055 mg
    CHF 630.00
    MOTS-c (K14Q Mutant) (human)
  8. Mubritinib
    CAS  366017-09-6
    AG-CR1-3755
    AG-CR1-3755-M0055 mg
    CHF 35.00
    AG-CR1-3755-M02525 mg
    CHF 140.00
    Mubritinib
  9. N-Acetyl-D-glucosamine
    CAS  7512-17-6
    AG-CN2-0489
    AG-CN2-0489-M250250 mg
    CHF 15.00
    AG-CN2-0489-G0011 g
    CHF 25.00
    AG-CN2-0489-G0055 g
    CHF 65.00
    N-Acetyl-D-glucosamine
  10. N1-Guanyl-1,7-diaminoheptane [GC7]
    CAS  150417-90-6 (parent 150333-69-0)
    AG-CR1-3702
    AG-CR1-3702-M01010 mg
    CHF 140.00
    AG-CR1-3702-M05050 mg
    CHF 420.00
    N1-Guanyl-1,7-diaminoheptane [GC7]

Items 41-50 of 116

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.